Clinical Trial Update: Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-A1811 in HER2-positive metastatic breast cancer with brain metastases; recruitment is ongoing. The study is sponsored by H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING